Every SEC Form 3/4/5 on record for this filer (CIK 1228922) — 10 issuers, 500 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NXDT | NEXPOINT DIVERSIFIED REAL ESTATE TRUST | See Remarks · Director | 2021-11-17 → 2026-06-12 | 79 | $22M |
| NXRT | NexPoint Residential Trust, Inc. | President · Director | 2015-07-02 → 2026-05-27 | 93 | −$40M |
| NREF | NexPoint Real Estate Finance, Inc. | President · Director | 2020-02-06 → 2026-04-06 | 63 | $7M |
| NRSAX | NEXPOINT REAL ESTATE STRATEGIES FUND | See Remarks · lapsed | 2022-03-17 → 2023-09-18 | 2 | −$5M |
| PRTK | Paratek Pharmaceuticals, Inc. | 10% owner · lapsed | 2023-03-29 → 2023-03-29 | 2 | $1M |
| NHF | NexPoint Strategic Opportunities Fund | See Remarks · lapsed | 2018-06-11 → 2021-11-02 | 27 | $1M |
| JCAP | Jefferson Capital, Inc. / DE | Director · lapsed | 2016-08-10 → 2020-11-09 | 30 | $608,983 |
| PCO | Pendrell Corp | 10% owner · lapsed | 2015-12-29 → 2017-10-16 | 8 | −$913,542 |
| NRESF | NEXPOINT REAL ESTATE STRATEGIES FUND | See Remarks · lapsed | 2016-11-21 → 2017-08-15 | 2 | −$82,940 |
| RLYP | Relypsa Inc | 10% owner · lapsed | 2016-08-08 → 2016-08-18 | 4 | −$1M |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
4 of 10 issuers are covered and open a security page; the rest are on file here only.